Invesaro

Stocks Health care ALRTF

OTC · Health care

ALR Technologies SG Ltd. (ALRTF)

It posted a net loss of $22.1M. At December 31, 2025 it held $20.3K in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 30, 2026.

Free, no password. An email when ALRTF files with the SEC.

Price
$0.02
+5.63% on the day · November 9, 2026
52-week range $0.01 to $0.02

Key facts about ALR Technologies SG Ltd.

Net worth
ALR Technologies SG Ltd. reported shareholders' equity (book value: assets minus liabilities) of -$39.9M at December 31, 2025. We hold no current market value for it.
Revenue and profit
In fiscal 2023 revenue was $25.5K (+978.8% year on year), with a net loss of $7.5M.
Cash flow
In fiscal 2025 operations used $1.9M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on April 30, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What ALR Technologies SG Ltd. does

ALR Technologies SG Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker ALRTF.

Revenue and profit by year

Revenue
FY22: $7.5K $7.5K FY22FY22: $2.4K $2.4K FY22FY23: $25.5K $25.5K FY23
Net income
FY20: -$5.9M -$5.9M FY20FY22: -$8.4M -$8.4M FY22FY22: -$10.6M -$10.6M FY22FY23: -$7.5M -$7.5M FY23FY24: -$15.9M -$15.9M FY24FY25: -$22.1M -$22.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/an/a-$22.1M-$0.04n/a
2024n/an/a-$15.9M-$0.03n/a
2023$25.5Kn/a-$7.5M-$0.01n/a
2022$2.4K$4.3M-$10.6M-$0.02n/a
2022$7.5K$2.9M-$8.4Mn/an/a
2020n/a$3.8M-$5.9Mn/an/a

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What ALR Technologies SG Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. June 30, 2026
  2. May 20, 2026
  3. April 30, 2026
    Annual report (foreign issuer) 20-F · period to December 31, 2025Diluted EPS -$0.04 versus -$0.03.
  4. January 5, 2026
  5. December 30, 2025
  6. December 30, 2025
  7. July 7, 2025
  8. June 26, 2025
  9. May 2, 2025
    Annual report (foreign issuer, amended) 20-F/A · period to December 31, 2024Diluted EPS -$0.03 versus -$0.01.
  10. May 1, 2025

Recent insider filings (Forms 3, 4 and 144): 6, the latest on May 15, 2026. Insider transactions on SEC

Insider trades

What the people running ALR Technologies SG Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about ALRTF

What does ALR Technologies SG Ltd. do?

ALR Technologies SG Ltd. is a company in the Health care sector, listed on OTC as ALRTF. Its shares trade on OTC under the ticker ALRTF.

What is ALR Technologies SG Ltd.'s net worth?

ALR Technologies SG Ltd. reported shareholders' equity (book value: assets minus liabilities) of -$39.9M at December 31, 2025. We hold no current market value for it.

Is ALR Technologies SG Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $22.1M.

When did ALR Technologies SG Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 30, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from June 30, 2026.

Similar companies

Compare ALRTF with

Compare ALRTF with any company

Follow ALRTF

Get an email when ALR Technologies SG Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when ALRTF files with the SEC.

Where the numbers come from

Financial figures are the values ALR Technologies SG Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.